Research Articles | Challenge Journal of Perioperative Medicine

Factors associated with new-onset atrial fibrillation after coronary stent implantation: A single-center retrospective cohort study

Esma Selva Ateş Ceyhun
Esma Selva Ateş Ceyhun iD * Department of Cardiology, Erzurum City Hospital, Erzurum, Türkiye
View Counter: Abstract | 34 times | ‒ Full Article | 19 times |
Citation Metadata Academic search Print
Email (login required) Facebook X (Twitter) LinkedIn Reddit WhatsApp
Contact author (login required)

Abstract

Background: New-onset atrial fibrillation is a clinically relevant complication that may occur after coronary stent implantation. Although several clinical and echocardiographic factors have been associated with post-procedural atrial fibrillation, the relationship between coronary anatomical disease burden and early new-onset atrial fibrillation remains incompletely characterized. Therefore, this study aimed to investigate the association between coronary anatomical disease burden and early new-onset atrial fibrillation in patients undergoing coronary stent implantation.

Methods: We retrospectively evaluated 450 patients who underwent coronary stent implantation between January 2018 and December 2025. Patients with a previous history of atrial fibrillation, permanent pacemaker implantation, moderate-to-severe valvular heart disease, or incomplete clinical data were excluded. Patients were monitored for the occurrence of documented new-onset atrial fibrillation during the seven-day observation period. Clinical, laboratory, echocardiographic, and angiographic characteristics were compared between patients who developed atrial fibrillation and those who did not. Coronary anatomical complexity was assessed using the SYNTAX score. Multivariable logistic regression analysis was performed to identify factors independently associated with new-onset atrial fibrillation.

Results: New-onset AF was documented in 37 patients (8.2%). Patients who developed AF were older and had larger left atrial diameter and higher SYNTAX scores than those without AF. In multivariable logistic regression analysis, increasing age (adjusted OR, 1.07; 95% CI, 1.03–1.11; p = 0.001), larger left atrial diameter (adjusted OR, 1.15; 95% CI, 1.07–1.24; p < 0.001), and higher SYNTAX score (adjusted OR, 1.09; 95% CI, 1.04–1.15; p < 0.001) were independently associated with new-onset AF. Given the limited number of AF events, these associations should be interpreted cautiously.

Conclusion: In this retrospective cohort of patients undergoing coronary stent implantation, older age, larger left atrial diameter, and higher SYNTAX score were independently associated with documented new-onset atrial fibrillation within seven days. These findings suggest that both atrial structural characteristics and coronary anatomical disease burden may be relevant to early post-procedural atrial fibrillation. However, the findings are exploratory and should be confirmed in larger prospective studies incorporating systematic rhythm monitoring.

Keywords

new-onset atrial fibrillation; percutaneous coronary intervention; coronary stent implantation; SYNTAX score

References

Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47. https://doi.org/10.1161/CIRCULATIONAHA.113.005119

Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746-51. https://doi.org/10.1093/eurheartj/eht280

Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011;123(15):1587-93. https://doi.org/10.1161/CIRCULATIONAHA.110.986661

Jabre P, Jouven X, Adnet F, Thabut G, Bielinski SJ, Weston SA, et al. Atrial fibrillation and death after myocardial infarction: a community study. Circulation. 2011;123(19):2094-100. https://doi.org/10.1161/CIRCULATIONAHA.110.990192

Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, et al. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart. 2008;94(7):867-73. https://doi.org/10.1136/hrt.2007.134486

Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453-68. https://doi.org/10.1161/CIRCRESAHA.114.303211

Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014;16(11):1655-73. https://doi.org/10.1093/europace/euu208

Mrdovic I, Savic L, Krljanac G, Perunicic J, Asanin M, Lasica R, et al. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial. Coron Artery Dis. 2012;23(1):1-8. https://doi.org/10.1097/MCA.0b013e32834df552

Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92(10):1150-4. https://doi.org/10.1016/j.amjcard.2003.07.021

Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038-45. https://doi.org/10.1093/eurheartj/ehn579

Lancini D, Prasad A, Thomas L, Atherton J, Martin P, Prasad S. Predicting new onset atrial fibrillation post acute myocardial infarction: Echocardiographic assessment of left atrial size. Echocardiography. 2023;40(6):456–63. https://doi.org/10.1111/echo.15574

Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014;16(11):1655–73. https://doi.org/10.1093/europace/euu208

Khalfallah M, Elsheikh A. Incidence, predictors, and outcomes of new-onset atrial fibrillation in patients with ST-elevation myocardial infarction. Ann Noninvasive Electrocardiol. 2020;25(4):e12746. https://doi.org/10.1111/anec.12746

Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30(2):406-13. https://doi.org/10.1016/s0735-1097(97)00194-0

Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89(2):724–30. https://doi.org/10.1161/01.cir.89.2.724

Gorenek B, Parspur A, Timuralp B, Birdane A, Ata N, Cavusoglu Y, et al. Atrial fibrillation after percutaneous coronary intervention: predictive importance of clinical, angiographic features and P-wave dispersion. Cardiology. 2007;107(3):203-8. https://doi.org/10.1159/000095418

Arslan Ş, Batıt S, Kılıçarslan O, Doğan Ö, Yumuk MT, Arslan Ş, et al. Incidence of atrial fibrillation and its effects on long-term follow-up outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Anatol J Cardiol. 2021;25(9):609-16. https://doi.org/10.5152/AnatolJCardiol.2021.26020

Pan LH, Yan BY, Zhu J, Lu Q, Hui J. Effects of using primary percutaneous coronary interventions on the incidence of new-onset atrial fibrillation following an acute myocardial infarction. Clin Cardiol. 2024;47(1):e24167. https://doi.org/10.1002/clc.24167


Related Articles